World Health Organization Recommended CBD Shouldn’t Be Classified as a Scheduled 1 Substance
by Jack Chung
A year ago
On December 14, 2017, the health agency of the United Nations, World Health Organization (WHO), officially recommended the non-psychoactive cannabis compound, cannabidiol (CBD), not be internationally scheduled as a controlled substance. WHO research found that the therapeutic use and side effects of CBD is safe, with no potential for abuse or dependence, and not a public danger.
Report from Expert Committee on Drug Dependence (ECDD)
“In its pure state, cannabidiol does not appear to have abuse potential or cause harm. To date, there is no evidence of recreational use of CBD or any public health-related problems associated with the use of pure CBD.”
“Recent evidence from animal and human studies shows that its use could have some therapeutic applications. Current evidence also shows that cannabidiol is not likely to be abused or create dependence as for other cannabinoids (such as Tetra Hydro Cannabinol (THC), for instance).”
The ECDD therefore concluded that current information does not justify scheduling of cannabidiol and postponed a fuller review of CBD preparations to mid-2018, when the committee will go through a more comprehensive review of cannabis and cannabis-related substances.
With the support of WHO and the overwhelming scientific studies and research on the benefits of CBD, we are hopeful our country will eventually reevaluate its stance, and fully embrace and accept this phenomenal gift from nature.